166 related articles for article (PubMed ID: 16492144)
1. Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes.
Singh J; Deng Z; Narale G; Chuaqui C
Chem Biol Drug Des; 2006 Jan; 67(1):5-12. PubMed ID: 16492144
[TBL] [Abstract][Full Text] [Related]
2. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
Deng Z; Chuaqui C; Singh J
J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
[TBL] [Abstract][Full Text] [Related]
3. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
5. CORES: an automated method for generating three-dimensional models of protein/ligand complexes.
Hare BJ; Walters WP; Caron PR; Bemis GW
J Med Chem; 2004 Sep; 47(19):4731-40. PubMed ID: 15341488
[TBL] [Abstract][Full Text] [Related]
6. A pharmacophore map of small molecule protein kinase inhibitors.
McGregor MJ
J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
[TBL] [Abstract][Full Text] [Related]
7. Doing more than just the structure-structural genomics in kinase drug discovery.
Marsden BD; Knapp S
Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
[TBL] [Abstract][Full Text] [Related]
8. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
9. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
Sheinerman FB; Giraud E; Laoui A
J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
[TBL] [Abstract][Full Text] [Related]
10. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
Aronov AM; McClain B; Moody CS; Murcko MA
J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
[TBL] [Abstract][Full Text] [Related]
11. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
Frembgen-Kesner T; Elcock AH
J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a RET TK catalytic domain by homology modeling.
Tuccinardi T; Manetti F; Schenone S; Martinelli A; Botta M
J Chem Inf Model; 2007; 47(2):644-55. PubMed ID: 17295463
[TBL] [Abstract][Full Text] [Related]
13. Can MM-PBSA calculations predict the specificities of protein kinase inhibitors?
Page CS; Bates PA
J Comput Chem; 2006 Dec; 27(16):1990-2007. PubMed ID: 17036304
[TBL] [Abstract][Full Text] [Related]
14. Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
Pierce AC; Sandretto KL; Bemis GW
Proteins; 2002 Dec; 49(4):567-76. PubMed ID: 12402365
[TBL] [Abstract][Full Text] [Related]
15. Structural biology contributions to tyrosine kinase drug discovery.
Cowan-Jacob SW; Möbitz H; Fabbro D
Curr Opin Cell Biol; 2009 Apr; 21(2):280-7. PubMed ID: 19208462
[TBL] [Abstract][Full Text] [Related]
16. Transplant-insert-constrain-relax-assemble (TICRA): protein-ligand complex structure modeling and application to kinases.
Meshkat S; Klon AE; Zou J; Wiseman JS; Konteatis Z
J Chem Inf Model; 2011 Jan; 51(1):52-60. PubMed ID: 21117680
[TBL] [Abstract][Full Text] [Related]
17. Novel protein kinases and molecular mechanisms of autoinhibition.
Cheetham GM
Curr Opin Struct Biol; 2004 Dec; 14(6):700-5. PubMed ID: 15582394
[TBL] [Abstract][Full Text] [Related]
18. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
19. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
Verkhivker GM
Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
[TBL] [Abstract][Full Text] [Related]
20. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints.
Deng Z; Chuaqui C; Singh J
J Med Chem; 2006 Jan; 49(2):490-500. PubMed ID: 16420036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
